CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 57 enrolled
Drug / intervention
Stabilized chlorine dioxide oral rinse +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04838054
NCT04838054Phase 4Completed

Pilot Study: The Efficacy of Stabilized Chlorine Dioxide Rinse as a Chemical Adjuvant for Treatment of Peri-implant Mucositis

Rowpar Pharmaceuticals, Inc.·interventional·Posted Apr 8, 2021·Updated Apr 14, 2022

In Brief

A Phase 4 clinical trial evaluating Stabilized chlorine dioxide oral rinse and Placebo for Peri-implant Mucositis. Completed, enrolled 57 participants across 1 site.

Detailed Summary

A full understanding of etiology and diagnosis of peri-implant diseases is crucial for finding effective treatments for these diseases that are more widely accessible to dentists. Several treatment protocols for peri-implant diseases have been proposed, but no gold standard has been established to date. Thus, the purpose of this study is to analyze efficacy of stabilized chlorine dioxide as a chemical adjuvant for treatment of peri-implant mucositis in a non-surgical treatment protocol with a 3-month follow-up.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

Phase 4CompletedFinished
201820192020202120222023202420252026
First PostedApr 8, 2021
Enrollment StartMar 15, 2018
Primary CompletionJan 15, 2020
Study CompletionMar 4, 2020
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 5.2 years ago

Interventions

Stabilized chlorine dioxide oral rinsedrug

Patients received stabilized chlorine dioxide rinse associated with periodontal basic therapy.

Placeboother

Patients received a rinse containing no active ingredients and periodontal basic therapy.